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Abstract: The M,-selective (high affinity for pirenzepine) musca- 
rink acetylcholine receptor (mAChR) antagonist pirenzepine dis- 
placed both N-[3H]methylscopolamine ( [3H]NMS) and [3H]qui- 
nuclidinylbenzilate from intact human SK-N-SH neuroblastoma 
cells with a low affinity (K, = 869-1,066 M), a result indicating 
the predominance of the M2 or M3 (low affinity for pirenzepine) 
receptor subtype in these cells. Whereas a selective M2 agent, 
AF-DX 1 16 { 1 1-2[[2-[(diethylamino)methyl]-I-piperidinyl]- 
acetyl]-5,1 l-dihydro-6H-pyrido[2,3-b][ 1,4]benzodiazepin-6-one} 
bound to the mAChRs with a very low affinity (K, = 6.0 p M ) ,  
4diphenylacetoxy-N-methylpipendine methiodide (4-DAMP), an 
agent that binds with high affinity to the M3 subtype, potently 
inhibited ['HINMS binding (Ki = 7.2 nM). 4-DAMP was also 
1,000-fold more effective than AF-DX 116 at blocking stimulated 
phosphoinositide (PPI) hydrolysis in these cells. Covalent labeling 
studies (with [3H]propylbenzilylcholine mustard) suggest that the 
size of the SK-N-SH mAChR (M, = 8 1,000-98,000) distinguishes 
it from the predominant mAChR species in rat cerebral cortex (M, 
= 66,000), an M,-enriched tissue. These results provide the first 
demonstration of a neural M3 mAChR subtype that couples to PPI 
turnover. Key Words: Muscarinic receptor subtypes-Phospho- 
inositide turnover-Propylbenzilylcholine mustard-Pirenzepine. 
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Muscarinic acetylcholine receptors (mAChRs) are 
present in high concentrations in the CNS and are known 
to couple to a number of biochemical effector systems, such 
as stimulated phosphoinositide (PPI) turnover, inhibition 
of adenylate cyclase, and activation of guanylate cyclase 
(for review, see Nathanson, 1987). Subtypes of the mAChR 
have also been proposed on the basis of the differential 
ability with which pirenzepine binds to the receptor and 
inhibits the functional responses. Pirenzepine has a high 
affinity for the MI  subtype, whereas it has a low affinity for 
both the M2 and M3 subtypes. The latter can be differen- 
tiated on the basis of the relative selectivity of AF-DX 1 16 
{ 1 1 -2[[2-[(diethylamino)methyl]- l-piperidinyl]acetyl]-5,11 
-dihydro- 6H-pyrido[ 2 ,341  [ 1,4]benzodiazepin-6-0ne} 
for Mz and 4-DAMP (4-diphenylacetoxy-N-methylpiperi- 
dine methiodide) for M3 (Doods et al., 1987). The M2 and 
M3 receptors are principally found in heart and exocrine 
glands, respectively. In neural tissues, the MI subtype pre- 
dominates and couples to PPI turnover. In the present 
study, we demonstrate the presence of a high density of 
high-molecular-weight (M, > 80,000) mAChRs of the M3 
subtype in a neural cell line, human SK-N-SH neuroblas- 
toma. Furthermore, these receptors are shown to couple 
functionally to inositol lipid hydrolysis. 
MATERIALS AND METHODS 
my0-[2-~H]Inositol ( 1  5 Ci/mmol) was obtained from 
American Radiolabeled Chemicals (St. Louis, MO, 
U.S.A.). iV-[3H]MethylscopoIamine (t3H]NMS; 80 Ci/ 
mmol), [propyl-2,3-3H]benzilylcholine mustard ([3H]- 
PrBCM; 52 Ci/mmol), and [3H]quinuclidinylbenzilate 
([3H]QNB; 46 Ci/mmol) were obtained from New England 
Nuclear (Boston, MA, U.S.A.). Dowex-1 (100-200 mesh; 
X8 in the formate form) was obtained from Bio Rad Labs 
(Rockville Center, NY, U.S.A.). Pirenzepine and AF-DX 
1 16 were obtained from Boehnnger-Ingelheim (Ridgefield, 
CT, U.S.A.). 4-DAMP was a generous gift from Dr. Raj K. 
Goyal (Beth Israel Hospital, Boston, MA, U.S.A.). 
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Cell culture and biochemical determinations 
Human SK-N-SH neuroblastoma cells were cultured 
under conditions similar to those previously described 
(Fisher and Snider, 1987). In the experiments reported, 
14-22-day-old cells were used. Measurement of the binding 
of radioligands to intact cells and monitoring of PPI hydrol- 
ysis were as previously described (Fisher and Snider, 1987). 
Protein content was determined by the method of Geiger 
and Bessman (1972). 
Covalent labeling of muscarinic receptors 
Slices of adult rat cerebral cortex (Heacock et al., 1987) 
or intact SK-N-SH cells were preincubated [in buffer A, 
minus Ca2+ (Fisher and Snider, 1987)] in the presence or 
absence of 10 pM atropine for 15 min at 37"C, followed by 
addition of 5-10 nM cyclized [3H]PrBCM (Hunter and 
Nathanson, 1986). After 30 min at 37"C, tissues were pel- 
leted by centrifugation at low speed, washed twice with cold 
buffer A (minus Ca"), and then homogenized at 4°C in 
62.5 mMTris-HC1 (pH 6.8) containing the protease inhibi- 
tors phenylmethylsulfonyl fluoride (1 mM), phenanthro- 
line (0.5 mM), pepstatin A (0.1 p M ) ,  soybean trypsin in- 
hibitor ( 1  0 pg/ml), and EGTA (2 mM). Proteins were solu- 
bilized in 2% (wt/vol) sodium dodecyl sulfate (SDS), 1% 
6-mercaptoethanol, and 8 M urea. In some experiments, 
disulfide bond formation was blocked by alkylation with 
0.2 A4 iodoacetamide (Dadi and Morris, 1984). Samples 
were electrophoresed on 10% polyacrylamide gels 
(Laemmli, 1970), which contained 4 M urea. Coomassie 
Blue-stained gels were dried and then cut into 2-mm slices 
for determination of radioactivity (Hunter and Nathanson, 
1986). Alternatively, labeled proteins were visualized by 
fluorography . 
Data analysis 
Results are expressed as mean f SEM values. 
RESULTS AND DISCUSSION 
Specific binding of [3H]NMS and [3H]QNB to mAChRs 
on intact SIC-N-SH cells was saturable, with B,,, values of 
379 k 20 and 429 k 20 fmol bound/mg of protein, respec- 
tively. The corresponding KD values were I .2 1 f 0.22 and 
0.23 f 0.04 nM (n = 5). The binding of both radioligands 
could be displaced by pirenzepine, but with low affinity. 
The Ki values obtained for pirenzepine, 869 f 133 ([3H]- 
NMS) and 1,066 f 263 ([3H]QNB) nM(n = 5), suggest that 
M2 and/or M3 subtypes predominate in the SK-N-SH cell. 
Evidence that the M3 rather than the M2 receptor is present 
was obtained from studies with AF-DX 116 (M2 selective) 
and 4-DAMP (M3 selective). Both antagonists completely 
displaced [3H]NMS binding, but 4-DAMP was I ,000-fold 
more potent (Fig. 1). All three antagonists, i.e., pirenzepine, 
AF-DX 1 16, and 4-DAMP, blocked stimulated PPI hydrol- 
ysis with potencies that reflected the abilities of these agents 
to bind to the mAChR. Previously, we have shown that 
pirenzepine is a weak competitive inhibitor of stimulated 
PPI hydrolysis in SK-N-SH cells (Ki = 250 nA4) (Fisher and 
Snider, 1987). However, 4-DAMP is - 100-fold more po- 
tent than pirenzepine in the inhibition of stimulated PPI 
turnover, whereas AF-DX 1 16 is 10-fold less potent (Fig. 
2). Inclusion of increasing concentrations of both 4-DAMP 
and AF-DX 116 resulted in a parallel shift in the dose-re- 
sponse curves to carbamoylcholine, which is a characteris- 
tic of a competitive antagonist. Schild regression analysis of 
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FIG. 1. Inhibition of specific [3H]NMS binding to SK-N-SH cells by 
addition of 4-DAMP, pirenzepine, and AF-DX 116. Cells were 
incubated for 120 min at 37°C with the indicated concentrations 
of antagonists. The Ki values [calculated by the method of Cheng 
and Prusoff (1973)l were 7.2 k 1.5 nM, 869 f 133 nM, and 6.0 
k 2 pM for 4-DAMP, pirenzepine. and AF-DX 116, respectively (n 
= 4-5). 
the data yielded K, values of 1-3 nM for 4-DAMP and 
1.5-2 pM for AF-DX 1 16. These values are in good agree- 
ment with the affinity constants obtained from the radioli- 
gand binding data shown in Fig. 1. The differential abilities 
of pirenzepine, AF-DX 116, and 4-DAMP to bind 
mAChRs in SK-N-SH cells are very similar to that ob- 
served for the submandibular gland (an M3-containing tis- 
sue) but differs markedly from that observed in either the 
atrium (M2 containing) or hippocampus (MI containing) 
(Doods et al., 1987). That these three antagonists also ex- 
hibit the same relative affinities for inhibition of stimulated 
PPI turnover indicates that activation of M3 receptors can 
lead to the hydrolysis of inositol lipids. 
The possibility that the pharmacological characteristics 
of the mAChRs in SIC-N-SH cells might reflect the presence 
of different molecular species compared with that in an 
M,-containing tissue, such as the rat cerebral cortex, was 
explored. Intact SK-N-SH cells or rat cerebral cortex slices 
were labeled with [3H]PrBCM, and the labeled peptides 
were analyzed by SDS-urea gel electrophoresis (Fig. 3). Rat 
cortex contained a single species of M, 66,000 f 1,000 (n 
= 6), whereas SK-N-SH cells exhibited [3H]PrBCM-labeled 
peptides of considerably larger size with the major species 
of MI 98,000 f 2,000 (n = 6). The labeling of the less 
abundant M, 81,000 f 1,300 (n = 6) species varied but on 
the average accounted for approximately one-third of the 
total. In an experiment in which SK-N-SH cells were di- 
rectly homogenized in SDS-containing buffer, both species 
were present; however, the portion of radioactivity in the 
MI 81,000 species was reduced to 20% of the total. Thus, 
the possibility that the lower-M, species is, at least in part, 
derived from proteolysis of the MI 98,000 species cannot be 
ruled out. Rapid proteolysis of the mAChR in heart cells 
has been described (Hunter and Nathanson, 1986). Alter- 
natively, because mAChRs are glycoproteins (Rauh et al., 
1986), the MI 8 1,000 species may represent a reduced gly- 
cosylation state of the receptor. Alkylation of sulfhydryl 
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groups by iodoacetamide treatment had no effect on mi- 
gration of [3H]PrBCM-labeled peptides (Fig. 3, inset); thus, 
the higher molecular weight of the SK-N-SH mAChRs does 
not appear to result from intermolecular disulfide bond 
formation. Differences in proteolytic activity between rat 
cortex and SK-N-SH cells do not appear to be involved, 
because mixing of unlabeled rat cortex with labeled SK-N- 
SH cells before sample preparation had no effect on electro- 
phoretic migration of the mAChRs. It may be that the 
SK-N-SH mAChR is more heavily glycosylated than that in 
the cortex, a possibility that can be addressed by endogly- 
cosidase treatment (Rauh et al., 1986; Liang et al., 1987). 
Alternatively, the molecular and pharmacological charac- 
teristics of the mAChR expressed by SK-N-SH cells may 
reflect the presence of a receptor protein distinct from the 
species that predominates in the cerebral cortex. 
Muscarinic receptors thus far identified by [3H]PrBCM- 
labeling appear to fall into two groups: (a) those of M, 
65,000-80,000, found in brain (Venter, 1983; Dadi and 
Morris, 1984; Large et al., 1986), heart (Venter, 1983; 
Hunter and Nathanson, 1986), and NG108-15 cells (Hoot- 
man et al., 1985; Liang et al., 1987) and (b) those of M, 
-log [Carbamoylcholine] (M) 
FIG. 2. Schild analysis of inhibition by (A) 4-DAMP and (B) AF-DX 
1 1  6 of stimulated PPI turnover in SK-N-SH cells. Dose-response 
curves for stimulated inositol phosphate release were determined 
in the absence or presence of either 4-DAMP or AF-DX 1 1  6 at the 
concentrations indicated. Values shown are the means of tripli- 
cate replicates from a single experiment. Insets: The log of 
(dose-ratio - 1 )  is plotted as a function of 4-DAMP or AF-DX 1 1  6 
concentration. The calculated K, values were 1.5 nM and 1.5 pM 
for 4-DAMP and AF-DX 11  6, respectively. In a second experiment 
using the same experimental conditions, K, values of 3.1 nM and 
1.9 &I were calculated for these two antagonists. 
FIG. 3. SDS-urea gel electrophoresis of [3H]PrBCM-labeled 
mAChRs. Proteins (300-350 bg) from labeled SK-N-SH cells (0) 
or rat cortex slices (0) were subjected to electrophoresis as de- 
scribed in Materials and Methods. The ratio of specific to nonspe- 
cific (plus 10 WM atropine) labeling in the homogenate sample was 
8.5:l for SK-N-SH cells and 3.5:l for cortex. No radioactive peaks 
were detected in lanes containing tissue labeled in the presence of 
atropine (data not shown). Inset: Fluorograph of a duplicate gel 
(exposed for 20 days) with (lanes 1 and 2) SK-N-SH cell homoge- 
nate and (lanes 3 and 4) cortical homogenate. Samples in lanes 2 
and 4 were iodoacetamide treated. The molecular weight 
markers, in order of decreasing M,, were the following: myosin, 
B-galactosidase, phosphorylase b, bovine serum albumin, ovalbu- 
min, and carbonic anhydrase. 
> 80,000, found in SK-N-SH cells, exocrine glands (Hoot- 
man et al., 1985), and 1321N1 astrocytoma cells (Liang et 
al., 1987). Data presently available are suggestive of but 
insufficient to conclude whether or not the pharmacologi- 
cally defined mAChR subtypes can be definitively assigned 
to either of these groups. Of the mAChRs thus far se- 
quenced (Bonner et al., 1987), three are of similar size, 
whereas one (termed m3) is considerably larger. Screening 
of SK-N-SH cell mRNAs with the appropriate molecular 
probes will be necessary for determining whether its 
mAChR belongs to the latter category. 
The present results implicating the M3 subtype in PPI 
hydrolysis, together with previous reports implicating both 
MI  and M2 subtypes (Fisher and Agranoff, 1987), indicate 
that multiple mAChR subtypes with distinct pharmacologi- 
cal and molecular characteristics are able to couple to the 
same functional response. 
Acknowledgment: The authors wish to thank Ms. Lisa 
Domask for technical assistance and Ms. Jo Ann Kelsch for 
preparation of the manuscript. This work was supported by 
NIH grant NS 2383 1 (S.K.F.) and NIMH grant MH 42652 
(S.K.F. and A.M.H.). 
REFERENCES 
Bonner T. I., Buckley J. N., Young A. C., and Brann M. R. (1987) 
Identification of a family of muscarinic acetylcholine receptor 
genes. Science 237, 527-532. 
Cheng Y.-C. and Prusoff W. H. (1973) Relationship between the 
inhibition constant (K,) and the concentration of inhibitor 
which causes 50 percent inhibition (ICso) of an enzymatic 
reaction. Biochem. Pharmacol. 22, 3099-3 108. 
J. Neurochem., Vol. SO. No. 3, 1988 
M3 MUSCARINIC RECEPTORS 98 7 
Dadi H. K. and Moms R. J. (1  984) Muscarinic cholinergic receptor 
of rat brain. Factors influencing migration in electrophoresis 
and gel filtration in sodium dodecyl sulphate. Eur. J .  Biochem. 
144,617-628. 
Doods H. N., Mathy M.-J., Davidesko D., van Charldorp K. J., de 
Jonge A., and van Zwieten P. A. (1987) Selectivity of musca- 
rinic antagonists in radioligand and in vivo experiments for the 
putative M I ,  Mz and M3 receptors. J.  Pharmacol. Exp. Ther. 
Fisher S. K. and Agranoff B. W. (1987) Receptor activation and 
inositol lipid hydrolysis in neural tissues. J. Neurochem. 48, 
Fisher S. K. and Snider R. M. (1987) Differential receptor occu- 
pancy requirements for muscarinic cholinergic stimulation of 
inositol lipid hydrolysis in brain and in neuroblastomas. Mol. 
Pharmacol. 32 , s  1-90. 
Geiger P. M. and Bessman S. P. (1972) Protein determination by 
Lowry’s method in the presence of sulfhydryl reagents. Anal. 
Biochem. 49,467-473. 
Heacock A. M., Fisher S. K., and Agranoff B. W. (1987) Enhanced 
coupling of neonatal muscarinic receptors in rat brain to 
phosphoinositide turnover. J. Neurochem. 48, 1904- 19 I 1. 
Hootman S. R., Picado-Leonard T. M., and Burnham D. B. (1985) 
Muscarinic acetylcholine receptor structure in acinar cells of 
mammalian exocrine glands. J. Biol. Chem. 260,4 186-4194. 
242,257-262. 
999-101 7. 
Hunter D. D. and Nathanson N. M. ( 1986) Biochemical and physi- 
cal analyses of newly synthesized muscarinic acetylcholine re- 
ceptors in cultured embryonic chicken cardiac cells. J .  Neuro- 
xi. 6, 3739-3748. 
Laemmli U. K. ( 1  970) Cleavage of structural proteins during the 
assembly of the head of bacteriophage T4. Nature 227, 
Large T. H., Lambert M. P., Gremillion M. A., and Klein W. L. 
(1 986) Parallel postnatal development of choline acetyltrans- 
ferase activity and muscarinic acetylcholine receptors of the 
rat olfactory bulb. J.  Neurochem. 46, 671-680. 
Liang M., Martin M. W., and Harden T. K. (1987) [3H]Propylben- 
zilylcholine mustard-labeling of muscarinic cholinergic recep- 
tors that selectively couple to phospholipase C or adenylate 
cyclase in two cultured cell lines. Mol. Pharmacol. 32, 
443-449. 
Nathanson N. M. ( I  987) Molecular properties of the muscarinic 
acetylcholine receptor. Annu. Rev. Neurosci. 10, 195-236. 
Rauh J. J., Lambert M. P., Cho N. J., Chin H., and Klein W. L. 
( 1986) Glycoprotein properties of muscarinic acetylcholine 
receptors from bovine cerebral cortex. J.  Neurochem. 46, 
Venter J. C. (1983) Muscarinic cholinergic receptor structure. Re- 
ceptor size, membrane orientation, and absence of major 




J. Neurochem.. Vol. 50, No. 3, 1988 
